Navigation and service

BIENNIAL REPORT 2019/2020

Welcome

Welcome

Research

Research

International

International

Regulation

Regulation

Organisation

Organisation

Data & Facts

Data & Facts

03.12.2020 back forward

COVID-19 Vaccine: Third Rolling Review Procedure

Document evaluation (Source: Aymanejed / Pixabay)

The Committee for Medicinal Products for Human Use (CHMP) at the European Medicines Agency (EMA) initiates a rolling review procedure for the COVID-19 vector vaccine from Janssen. The aim of the rolling review, in which the required data is submitted and evaluated successively, is to accelerate the marketing authorisation procedure. The requirements on the quality, safety and efficacy of the medicinal products nonetheless remain high.